A guide to the dutasteride-simvastatin drug interaction: CYP3A4 mechanism, clinical severity, rhabdomyolysis risk, monitoring parameters, and evidence-based dose guidance.
A clinician-level review of the dutasteride, SSRI drug interaction, covering CYP450 pharmacokinetics, sexual side-effect overlap, serotonin syndrome risk, and practical prescribing guidance for men on Avodart plus sertraline or escitalopram.
No drug-drug interaction exists between Jardiance and metformin, but declining kidney function raises metformin accumulation risk. Learn what to watch for.
A guide to the enclomiphene citrate and cannabis interaction, covering pharmacokinetics, hormone axis effects, CYP3A4 overlap, and practical dosing guidance.
A detailed clinical review of the enclomiphene citrate and gabapentin drug interaction, covering pharmacokinetic mechanisms, sedation risk, renal considerations, monitoring parameters, and patient counseling guidance.
Enclomiphene has no FDA-approved product and the Prometrium label lists no interaction with it. Covers label warnings and regulator safety concerns.
A guide to the epitalon and rosuvastatin interaction, covering mechanism, severity, monitoring parameters, and patient counseling for safe concurrent use.
A breakdown of how caffeine affects oral estradiol metabolism, CYP1A2 competition, estrogen exposure changes, and what this means for your HRT dose.
A detailed clinical review of the oral estradiol and acetaminophen drug interaction, covering hepatic mechanisms, DDI severity, monitoring parameters, dose-adjustment guidance, and patient counseling points with primary literature citations.
A guide covering the pharmacokinetic and pharmacodynamic interactions of oral estradiol with estradiol HRT, including VTE risk, CYP enzyme effects, monitoring protocols, and patient counseling points.
A guide to the oral estradiol and prednisone interaction, covering the corticosteroid-binding globulin mechanism, glucose and bone considerations, monitoring, and what remains unproven.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between oral estradiol and SSRIs like sertraline and escitalopram, including mechanism, severity, monitoring parameters, and an evidence-status assessment of what is known versus unverified.
A guide to the oral estradiol and trazodone drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling.
A clinical breakdown of the estradiol transdermal patch and caffeine interaction profile, including pharmacokinetic data, breast tenderness risk, and safe daily caffeine thresholds for women on HRT.
A guide to the estradiol patch and nicotine interaction, covering pharmacokinetics, cardiovascular risk, smoking cessation strategies, and safe HRT use for current and former smokers.
A guide to the pharmacokinetic and pharmacodynamic interactions between transdermal estradiol and benzodiazepines, including mechanism, severity, monitoring, and dose-adjustment guidance.
A guide to the estradiol patch and hormonal contraceptive interaction: mechanism, severity, monitoring, dose adjustment, and patient counseling backed by primary literature.
A clinician-level review of the estradiol patch and diphenhydramine interaction, covering pharmacokinetic mechanisms, CNS and anticholinergic risks, severity classification, monitoring protocols, and patient counseling points.
A clinical review of the estradiol transdermal patch and gabapentin drug interaction, covering mechanism, sedation risk, CNS overlap, monitoring protocols, and dose-adjustment guidance.
A clinician-level review of the pharmacokinetic and pharmacodynamic interactions between estradiol transdermal patches and SNRIs (venlafaxine, duloxetine), including mechanism, monitoring, dose adjustment, and patient counseling.
A full pharmacological review of the estradiol patch and tadalafil interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling guidance.
A guide to the pharmacodynamic overlap between estradiol transdermal patches and testosterone therapy, including monitoring considerations, dose principles, and where the evidence is solid versus where it is not.
A guide to the estradiol patch and trazodone interaction covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for safer co-administration.
Can you take Lunesta (eszopiclone) with acetaminophen (Tylenol)? A guide covering the mechanism, evidence status, monitoring, and safe dosing for this drug combination.
A clinician-level review of the eszopiclone, diphenhydramine drug interaction, covering mechanism, severity, dose guidance, monitoring, and patient counseling backed by primary literature.
A guide to the eszopiclone-trazodone drug interaction: mechanism, severity, dose guidance, monitoring, and patient counseling based on FDA labeling and primary literature.
A clinician-level review of the evolocumab (Repatha) and estradiol HRT interaction, covering mechanism, VTE risk, lipid effects, monitoring protocols, and patient counseling guidance.
A detailed clinical review of the evolocumab (Repatha) and progesterone HRT interaction, covering mechanism, DDI severity, monitoring parameters, dose adjustment, and patient counseling backed by primary literature.
A guide to the evolocumab (Repatha) and NSAID interaction, covering pharmacology, cardiovascular and renal risks, monitoring parameters, and practical patient counseling.
A comprehensive clinical guide to the ezetimibe and estradiol HRT interaction, covering mechanism, VTE and breast-cancer risk overlap, monitoring parameters, and patient counseling, prepared by the HealthRX.com Editorial Team.
A comprehensive guide to the ezetimibe, tadalafil drug interaction, covering mechanism, safety evidence, monitoring, and dosing guidance.
A clinical review of how cannabis (THC and CBD) interacts with finasteride pharmacokinetics, hormonal effects, and side-effect risk, with dosing guidance and physician sign-off.
A deep dive into the finasteride-nicotine interaction, covering pharmacokinetics, cardiovascular risk, sexual side-effect overlap, and practical guidance for men using nicotine products while on finasteride.
A comprehensive guide to finasteride's vaccine interaction profile, including immunologic mechanism, clinical evidence, alcohol considerations, and practical dosing guidance.
A clinician-level review of the finasteride and opioid interaction, covering CYP enzyme pathways, pharmacodynamic overlap, CNS/respiratory depression risk, monitoring parameters, and patient counseling points for oxycodone, hydrocodone, and tramadol.
Can you take finasteride with simvastatin? An evidence-based look at the CYP3A4 mechanism, what is established versus plausible, and what a clinician or pharmacist should verify before combining these drugs.
A clinician-level review of the flibanserin (Addyi) and apixaban drug interaction, covering CYP3A4 and P-glycoprotein mechanisms, bleeding risk, severity classification, monitoring parameters, and patient counseling points.
A look at whether GHK-Cu (copper tripeptide) interacts with hormonal contraceptives, covering mechanism, copper physiology, CYP enzymes, and safe-use guidance.
A guide to the GHK-Cu and warfarin interaction, covering mechanism, INR monitoring, dose-adjustment principles, and patient counseling based on primary literature.
A guide to the pharmacodynamic interaction between insulin glargine (Lantus) and estradiol HRT, covering mechanism, blood glucose monitoring, dose adjustment, and patient counseling.
No interaction between ipamorelin and prednisone has been established. This page covers what is known about blood sugar and potassium for each drug.
An evidence-based review of the ipamorelin and trazodone combination, covering the sedation overlap between the two drugs, what is and is not established about growth hormone axis effects, and what to verify with a prescriber or pharmacist.
A comprehensive clinical guide to isotretinoin's anesthesia and perioperative interactions, covering airway dryness, hepatotoxicity overlap, bleeding risk, wound healing delay, and safe surgical timing.
A clinician-level review of the isotretinoin, apixaban drug interaction, covering CYP3A4/P-gp mechanisms, bleeding risk, monitoring parameters, and patient counseling backed by primary literature and FDA labeling.
A deep dive into the isotretinoin, clopidogrel drug interaction: CYP2C19 mechanism, clinical severity, monitoring parameters, dose considerations, and patient counseling points.
An evidence-status review of the isotretinoin and estradiol HRT combination, covering mechanism, triglyceride and VTE risk, monitoring, and what remains unverified.
A detailed clinical review of the isotretinoin and rosuvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling based on primary literature and FDA labeling.
Neither the Accutane label nor the Zoloft label names the other drug as an interacting drug, but each carries its own mood-related warning.
A guide to the isotretinoin and testosterone interaction, covering mechanism, polycythemia risk, lipid monitoring, dose considerations, and patient counseling for anyone on TRT or anabolic testosterone.
Can you take Jatenzo with ibuprofen or naproxen? A board-reviewed clinical breakdown of the GI, renal, cardiovascular, and bleeding risks when combining oral testosterone undecanoate with NSAIDs, with monitoring protocols and patient counseling points.
What the Dayvigo label says about combining lemborexant with other CNS depressants, how long it stays active, and one perioperative study.
A guide to the lemborexant, estradiol HRT drug interaction: CYP3A4 metabolism, pharmacodynamic overlap, VTE and CNS risk, dose guidance, and monitoring protocols.
A clinical deep-dive into the lemborexant (Dayvigo) and progesterone HRT drug interaction, covering CYP3A4 pharmacokinetics, additive sedation risk, dose-adjustment guidance, and patient counseling points.
A guide to the lemborexant, sildenafil drug interaction: CYP3A4 mechanism, hypotension risk, dose guidance, and monitoring for patients taking both Dayvigo and sildenafil.
A detailed clinical review of the levothyroxine, apixaban drug interaction: mechanism, severity, monitoring parameters, dose considerations, and patient counseling based on FDA labeling and primary literature.
Can you take Synthroid with ibuprofen or naproxen? Learn the clinical mechanisms, risk levels, monitoring parameters, and patient counseling points for the levothyroxine-NSAID interaction.
A guide to the levothyroxine-prednisone drug interaction: mechanism, clinical severity, TSH monitoring schedule, dose adjustment, and patient counseling points.
Oral estrogens can raise thyroxine-binding globulin, which changes total T4 and T3 test values. Labels advise monitoring thyroid function, not spacing.
A clinical deep-dive into the liraglutide and rivaroxaban drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling points backed by primary literature.
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between liraglutide and rosuvastatin, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.